Moonbear said:
By the way, you don't "breed" resistance for drugs, you select for resistance. The gene for resistance had to already exist in the virus.
Cool, I always love it when people throw semantics at me.
I guess I'll go home now and tell my father he never actually used to breed championship boxers ... he selected for them.
So what you are saying is that now the main virus, the H5N1 has mutated to become resistant to Tamiflu, we have to wait for a version of 'SARS' which is a mutation that not only spreads between humans but also mutates to a weaker strain without the resistance of the main strain.
You'll also find that Tamiflu is a prophylactic for all flu, not just the SARS varient and seems to have its widest use in Vietnam and Japan both of whom have reported Tamiflu resistant strains.
Since it has been hypothesized that the origin of the future virus will be SE Asia and the Tamiflu antiviral is in rampant use there now, what we'll be hit by is most likely to be Tamiflu resistant strain.
What came out of http://www.cnn.com/2005/WORLD/asiapcf/09/30/birdflu.drugs.reut/" was a warning that we are putting all our eggs in one basket.
Since Tamiflu is a pill that has storage capabilities at room temperature, Roche has won out in the popularity wars at the expense of Relenza which is just as effective however it is an inhalent.
What is happening is that the work of 'Ward' (A Roche Pharmaceutical Engineer) is being publicised as the dfinitive work on the subject and the possibilities are running that not only will we be running at 100% production on Tamivar in the Roche labs but we will be converting over the generics to production of this medicine too.
Basically, the Hong Kong warning is that we are setting ourselves up for a big fall.
If it gets away from is in SE Asia which is using Tamivar in 100% of suspect cases, it will have to be a Tamivar resistant version.
Now, I am sure that Roche is very happy you are buying their product. They are even happier still that governments are not ony encouraging it's production they are even recomending they license production to the Generics. Never before in history has a Drug company been
ordered to make money on this scale.
The problem is that when the virus finally hits the good ole USofA, you might as well suck the cardboard from the carton it comes in for all the good it will do you.
Since Tamivar is being used as the first line of defence in the nations originating the virus, it only follows that the pandemic will be resistant if it escapes and your only 'defence' is going to be the second line ... Relenza ... the inhalent (Which the HK doctors say should be receiving the attention it needs to produce at least an IV version).
Here's the plain, simple facts ... because Tamivar was used in the treatment of SARS and was found to be successful, the treatment of SARS reduced the fatalities to 10%. It is currently estimated that if a Tamiflu resistant strain goes global (Pandemic) we'll be looking at up to 70% fatalities.
The sad fact is, you won't be able to get Relenza for love nor money.
http://www.recombinomics.com/News/10150501/H5N1_H2H_Tamiflu.html" a little blurb on what they are seeing in Vietnam.